Tox21_300575

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers, 12 USDMF, 2 CEP/COS, 1 EU WC, 4 NDC API, 5 Listed Suppliers

DOSSIERs // Finished Dosage Forms

81 Dossiers, 29 FDA Orange Book, 28 Europe, 18 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SOLUTION;ORAL - 10MG/ML, CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 18 BASF, 15 Kerry, 13 Corel Pharma Chem, 12 Roquette, 11 Sigachi Industries, 9 Ideal Cures Pvt Ltd, 7 Gangwal Chemicals, 7 Gangwal Healthcare, 7 Seppic, 6 Microlex e.U, 6 Lonza Capsugel, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 ACG Worldwide, 4 Kima Chemical, 4 DFE Pharma, 3 Prachin Chemical, 3 The Dow Chemical Company, 3 Vasa Pharmachem, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Actylis, 3 Doshion Polyscience, 2 Finar, 2 Seqens, 2 Nanjing Well Pharmaceutical, 2 Qualicaps, 2 Evonik, 2 Nomisma Healthcare, 2 Ingredion Pharma Solutions, 2 Pharmatrans-Sanaq, 1 SPI Pharma, 1 Vertellus, 1 Alcedo Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Jai Radhe Sales, 1 Rochem International Inc, 1 Aeon Procare, 1 DKSH

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives, 36 Controlled & Modified Release, 27 Disintegrants & Superdisintegrants, 23 Fillers, Diluents & Binders, 20 Thickeners and Stabilizers, 15 Direct Compression, 13 Granulation, 13 Film Formers & Plasticizers, 12 Solubilizers, 11 Taste Masking, 10 Topical, 9 Empty Capsules, 7 Lubricants & Glidants, 6 Co-Processed Excipients, 5 Rheology Modifiers, 4 API Stability Enhancers, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 3 Parenteral, 2 Coloring Agents, 2 Emulsifying Agents, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

1 DOSSIERS // FDF

1 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

4 EDQM Standards, 4 USP Standards, 4 Other Ref. Standards

Latest U.S. Prescription Data for Drugs containing Tox21_300575 under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Tox21_300575

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers

12 USDMF

2 CEP/COS

1 EU WC

4 NDC API

5 Listed Suppliers

DOSSIERs // Finished Dosage Forms

81 Dossiers

29 FDA Orange Book

28 Europe

18 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SOLUTION;ORAL - 10MG/ML

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

18 BASF

15 Kerry

13 Corel Pharma Chem

12 Roquette

11 Sigachi Industries

9 Ideal Cures Pvt Ltd

7 Gangwal Chemicals

7 Gangwal Healthcare

7 Seppic

6 Microlex e.U

6 Lonza Capsugel

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 ACG Worldwide

4 Kima Chemical

4 DFE Pharma

3 Prachin Chemical

3 The Dow Chemical Company

3 Vasa Pharmachem

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Actylis

3 Doshion Polyscience

2 Finar

2 Seqens

2 Nanjing Well Pharmaceutical

2 Qualicaps

2 Evonik

2 Nomisma Healthcare

2 Ingredion Pharma Solutions

2 Pharmatrans-Sanaq

1 SPI Pharma

1 Vertellus

1 Alcedo Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 Jai Radhe Sales

1 Rochem International Inc

1 Aeon Procare

1 DKSH

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives

36 Controlled & Modified Release

27 Disintegrants & Superdisintegrants

23 Fillers, Diluents & Binders

20 Thickeners and Stabilizers

15 Direct Compression

13 Granulation

13 Film Formers & Plasticizers

12 Solubilizers

11 Taste Masking

10 Topical

9 Empty Capsules

7 Lubricants & Glidants

6 Co-Processed Excipients

5 Rheology Modifiers

4 API Stability Enhancers

4 Vegetarian Capsules

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons